Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. ITRM
ITRM logo

ITRM

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ITRM News

PMGC Holdings Unit Amends Clinical Trial Agreement

Mar 30 2026stocktwits

Iterum Therapeutics Files for Liquidation Amid Financial Struggles

Mar 30 2026NASDAQ.COM

Leading Pre-Market Gainers Today — ELAB, ITRM, LTRN Among Stocks Rising Ahead of Market Open

Mar 30 2026stocktwits

Iterum Therapeutics Files for Liquidation Amid Financial Struggles

Mar 27 2026Newsfilter

ITERUM THERAPEUTICS PLC - HEARING FOR WINDING UP PETITION SCHEDULED FOR APRIL 13, 2026 - SEC FILING

Mar 27 2026moomoo

U.S. Stocks Decline Amid Ongoing Iran-U.S. Conflict

Mar 03 2026Benzinga

Ouster Inc Reports Strong Q4 Results, Shares Surge

Mar 03 2026Benzinga

ITERUM THERAPEUTICS PLC: FDA Suggests Type C Meeting for Proposed Clinical Study of ORLYNVAH

Feb 13 2026moomoo

IO Biotech (IOBT) Explores Strategic Alternatives, Stock Surges 19.36%

Jan 22 2026NASDAQ.COM

Iterum Expands ORLYNVAH™ Coverage to 25 Million Lives in the U.S.

Dec 05 2025Globenewswire

Butterfly Network and Citius Pharma Boost Biotech Activity in After-Hours Trading

Nov 24 2025NASDAQ.COM

Applied Therapeutics, Omeros, and Others Experience Significant Price Changes After Market Close

Nov 14 2025NASDAQ.COM

Earnings Report Ahead of Market Opening for November 14, 2025: SR, SRRK, TWST, BTBT, SGML, FRGE, SBC, GAUZ, INKT, MRSN, ITRM, LMFA

Nov 13 2025NASDAQ.COM

Key Stocks Reporting Earnings This Week: Plug, Oklo, Circle, and Others

Nov 10 2025Benzinga

Iterum Therapeutics Projects Sufficient Cash Reserves Through 2026

Sep 20 2025Yahoo Finance

Iterum Therapeutics Shares Latest Business Developments

Sep 19 2025Newsfilter